Front Pharmacol. 2016 Apr 06;7:83. doi: 10.3389/fphar.2016.00083. eCollection 2016.
Pancreatic β Cell Mass Death.
Frontiers in pharmacology
Husnia I Marrif, Salma I Al-Sunousi
Affiliations
Affiliations
- Department of Pharmacology, Faculty of Medicine, University of Benghazi Benghazi, Libya.
- Department of Histology and Anatomy, Faculty of Medicine, University of Benghazi Benghazi, Libya.
PMID: 27092078
PMCID: PMC4821858 DOI: 10.3389/fphar.2016.00083
Abstract
Type two diabetes (T2D) is a challenging metabolic disorder for which a cure has not yet been found. Its etiology is associated with several phenomena, including significant loss of insulin-producing, beta cell (β cell) mass via progressive programmed cell death and disrupted cellular autophagy. In diabetes, the etiology of β cell death and the role of mitochondria are complex and involve several layers of mechanisms. Understanding the dynamics of those mechanisms could permit researchers to develop an intervention for the progressive loss of β cells. Currently, diabetes research has shifted toward rejuvenation and plasticity technology and away from the simplified approach of hormonal compensation. Diabetes research is currently challenged by questions such as how to enhance cell survival, decrease apoptosis and replenish β cell mass in diabetic patients. In this review, we discuss evidence that β cell development and mass formation are guided by specific signaling systems, particularly hormones, transcription factors, and growth factors, all of which could be manipulated to enhance mass growth. There is also strong evidence that β cells are dynamically active cells, which, under specific conditions such as obesity, can increase in size and subsequently increase insulin secretion. In certain cases of aggressive or advanced forms of T2D, β cells become markedly impaired, and the only alternatives for maintaining glucose homeostasis are through partial or complete cell grafting (the Edmonton protocol). In these cases, the harvesting of an enriched population of viable β cells is required for transplantation. This task necessitates a deep understanding of the pharmacological agents that affect β cell survival, mass, and function. The aim of this review is to initiate discussion about the important signals in pancreatic β cell development and mass formation and to highlight the process by which cell death occurs in diabetes. This review also examines the attempts that have been made to recover or increase cell mass in diabetic patients by using various pharmacological agents.
Keywords: apoptosis; autophagy; diabetes; insulin; protein folding; stem cells; β cells
References
- Free Radic Biol Med. 2000 Aug;29(3-4):222-30 - PubMed
- J Biol Chem. 2014 May 2;289(18):12435-45 - PubMed
- Diabetes. 2011 Mar;60(3):890-8 - PubMed
- Nat Clin Pract Endocrinol Metab. 2007 Nov;3(11):758-68 - PubMed
- Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a008656 - PubMed
- Diabetologia. 1982 Dec;23(6):525-8 - PubMed
- Diabetologia. 2008 Jan;51(1):91-100 - PubMed
- Mol Cell Biol. 2005 May;25(9):3752-62 - PubMed
- J Pharmacol Exp Ther. 2014 Sep;350(3):657-64 - PubMed
- BMJ Open. 2015 Oct 07;5(10):e007235 - PubMed
- Nature. 2003 Dec 18;426(6968):884-90 - PubMed
- Diabetes. 2005 Feb;54(2):452-61 - PubMed
- Methods Mol Biol. 2012;810:165-82 - PubMed
- Cell Physiol Biochem. 2011;28(5):873-86 - PubMed
- Lab Invest. 2010 Nov;90(11):1661-75 - PubMed
- Science. 2006 Dec 1;314(5804):1414-5 - PubMed
- PLoS One. 2013;8(3):e58655 - PubMed
- EBioMedicine. 2015 Mar 17;2(5):378-85 - PubMed
- Diabetes Care. 2009 Nov;32 Suppl 2:S151-6 - PubMed
- J Biol Chem. 2015 Mar 6;290(10 ):6071-85 - PubMed
- Diabetes Care. 2002 Feb;25(2):370-5 - PubMed
- Dev Cell. 2013 Jul 15;26(1):3-7 - PubMed
- Endocrinology. 2000 Jul;141(7):2350-60 - PubMed
- Transplant Proc. 2005 Mar;37(2):1305-8 - PubMed
- Front Biosci. 2008 May 01;13:5824-37 - PubMed
- Horm Res. 2008;70(3):165-73 - PubMed
- Am J Transplant. 2012 Jan;12(1):102-14 - PubMed
- Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1607-11 - PubMed
- Diabetes. 2002 Mar;51(3):686-90 - PubMed
- Endocrinology. 2006 Jul;147(7):3398-407 - PubMed
- Diabetes. 2005 Sep;54(9):2602-11 - PubMed
- Essays Biochem. 2010;47:53-67 - PubMed
- Cell. 2009 Aug 7;138(3):449-62 - PubMed
- Oxid Med Cell Longev. 2015;2015:639191 - PubMed
- Obes Rev. 2014 Oct;15 Suppl 4:107-24 - PubMed
- Diabetes. 2006 Dec;55(12):3289-98 - PubMed
- Clin Pharmacol Ther. 2015 Aug;98(2):162-9 - PubMed
- Am J Kidney Dis. 2015 Apr;65(4):634-6 - PubMed
- Diabetologia. 2007 Apr;50(4):752-63 - PubMed
- Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1750-7 - PubMed
- J Clin Invest. 1983 Jun;71(6):1544-53 - PubMed
- Mol Cell Endocrinol. 2011 Mar 30;335(2):104-9 - PubMed
- Nature. 2006 Oct 19;443(7113):787-95 - PubMed
- Mol Cell Neurosci. 1996;8(4):221-41 - PubMed
- J Biol Chem. 1996 Jan 12;271(2):1200-8 - PubMed
- Annu Rev Physiol. 2013;75:155-79 - PubMed
- Arq Bras Endocrinol Metabol. 2007 Mar;51(2):212-21 - PubMed
- Nature. 2003 Dec 18;426(6968):905-9 - PubMed
- Diabetologia. 1995 Dec;38(12):1405-11 - PubMed
- Dev Cell. 2010 Jun 15;18(6):1022-9 - PubMed
- PLoS One. 2013;8(1):e54173 - PubMed
- Trends Endocrinol Metab. 2011 Jul;22(7):266-74 - PubMed
- Biochem Soc Trans. 2008 Jun;36(Pt 3):353-6 - PubMed
- PLoS One. 2011;6(5):e20151 - PubMed
- Diabetologia. 1998 Jun;41(6):629-33 - PubMed
- J Histochem Cytochem. 2010 Apr;58(4):369-76 - PubMed
- Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1309-18 - PubMed
- Nat Protoc. 2014 Dec;9(12):2719-24 - PubMed
- Cell. 2006 Aug 25;126(4):663-76 - PubMed
- Physiol Rev. 2007 Jan;87(1):315-424 - PubMed
- N Engl J Med. 2015 Oct 29;373(18):1720-32 - PubMed
- Br J Pharmacol. 2012 Jun;166(3):877-94 - PubMed
- Diabetes Care. 2015 Aug;38(8):1441-8 - PubMed
- Physiol Res. 2001;50(6):537-46 - PubMed
- Dev Dyn. 2007 Dec;236(12):3451-8 - PubMed
- N Engl J Med. 1993 Sep 30;329(14):977-86 - PubMed
- Sci Rep. 2012;2:279 - PubMed
- Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29 - PubMed
- Cell Biochem Biophys. 2007;48(2-3):127-37 - PubMed
- Islets. 2010 May-Jun;2(3):135-45 - PubMed
- Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2334-9 - PubMed
- Nat Rev Drug Discov. 2012 Dec;11(12):937-57 - PubMed
- Biochem Biophys Res Commun. 2015 Apr 17;459(4):561-7 - PubMed
- J Ethnopharmacol. 1995 Nov 17;49(1):51-5 - PubMed
- Vitam Horm. 2009;80:409-71 - PubMed
- Dev Cell. 2002 Nov;3(5):631-43 - PubMed
- Mol Cancer Res. 2007 Jun;5(6):523-30 - PubMed
- Ann Intern Med. 1998 Apr 1;128(7):517-23 - PubMed
- Transpl Int. 2003 Jul;16(7):537-42 - PubMed
- Diabetes. 2003 Apr;52(4):991-7 - PubMed
- Diabetologia. 2013 Mar;56(3):542-52 - PubMed
- Biochem Biophys Res Commun. 2013 Nov 8;441(1):133-8 - PubMed
- Diabetol Metab Syndr. 2014 Aug 24;6(1):91 - PubMed
- Diabetes. 2003 Jan;52(1):102-10 - PubMed
- Pediatr Res. 2000 Jan;47(1):136-42 - PubMed
- J Biol Chem. 2009 Oct 2;284(40):27664-73 - PubMed
- Mol Endocrinol. 1989 Jan;3(1):165-73 - PubMed
- Diabetologia. 1996 May;39(5):548-57 - PubMed
- Nature. 2004 May 6;429(6987):41-6 - PubMed
- Mitochondrion. 2012 Jan;12(1):77-85 - PubMed
- Curr Neurovasc Res. 2015;12(4):404-13 - PubMed
- Cells. 2013 Apr 26;2(2):266-83 - PubMed
- Islets. 2009 Nov-Dec;1(3):177-84 - PubMed
- Eur J Endocrinol. 2002 Feb;146(2):129-41 - PubMed
- N Engl J Med. 2000 Jul 27;343(4):230-8 - PubMed
- Diabetes. 2009 Sep;58(9):2059-69 - PubMed
- Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1052-61 - PubMed
- Nat Genet. 1999 Sep;23(1):67-70 - PubMed
- Mol Ther. 2013 Jan;21(1):228-39 - PubMed
- Mol Cell Biol. 1999 Dec;19(12):8272-80 - PubMed
- Dev Biol. 2009 Feb 1;326(1):4-35 - PubMed
- J Biol Chem. 1999 Feb 26;274(9):5654-8 - PubMed
- Diabetes Metab J. 2013 Oct;37(5):375-84 - PubMed
- J Cell Physiol. 2010 Aug;224(2):501-8 - PubMed
- Acta Gastroenterol Latinoam. 2000;30(2):107-13 - PubMed
- Diabetes. 2002 Jun;51(6):1834-41 - PubMed
- Curr Diabetes Rev. 2011 Mar;7(2):106-25 - PubMed
- Trends Endocrinol Metab. 2015 Jul;26(7):337-8 - PubMed
- Cell Cycle. 2012 Jul 1;11(13):2431-42 - PubMed
- Int J Environ Res Public Health. 2015 Sep 10;12(9):11304-27 - PubMed
- Cell Transplant. 2013;22(8):1463-76 - PubMed
- Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14920-5 - PubMed
- Cells Tissues Organs. 2014;199(5-6):329-41 - PubMed
- Cold Spring Harb Perspect Med. 2012 Sep 01;2(9):a007666 - PubMed
- Genes Dev. 2008 Dec 15;22(24):3435-48 - PubMed
- Histol Histopathol. 2008 Jul;23(7):883-95 - PubMed
- Curr Biol. 2009 Dec 1;19(22):R1046-52 - PubMed
- J Intern Med. 2013 Jun;273(6):529-43 - PubMed
- J Histochem Cytochem. 1998 Jun;46(6):707-15 - PubMed
- Rev Diabet Stud. 2014 Summer;11(2):181-9 - PubMed
- Exp Diabetes Res. 2012;2012:509437 - PubMed
- Surv Synth Pathol Res. 1985;4(2):110-25 - PubMed
- Diabetes. 1999 Apr;48(4):927-32 - PubMed
- Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5407-12 - PubMed
- Regul Pept. 2006 Sep 11;136(1-3):78-84 - PubMed
- Cell. 1996 Oct 4;87(1):43-52 - PubMed
- Diabetes. 1999 Dec;48(12):2398-406 - PubMed
- Toxicol Pathol. 2007 Jun;35(4):495-516 - PubMed
- Diabetes. 2004 Dec;53(12):3107-14 - PubMed
- J Biol Chem. 2015 Aug 21;290(34):20687-99 - PubMed
- Oncogene. 2003 Aug 14;22(34):5261-9 - PubMed
- Diabetes Care. 2015 Jan;38 Suppl:S8-S16 - PubMed
- Bioinformation. 2013 Dec 27;9(20):1040-3 - PubMed
- PLoS One. 2012;7(2):e30555 - PubMed
- Diabetes. 2004 Dec;53 Suppl 3:S26-33 - PubMed
- Biochem J. 2012 Jan 15;441(2):523-40 - PubMed
- PLoS One. 2011;6(12):e28828 - PubMed
- Exp Clin Transplant. 2015 Feb;13(1):68-75 - PubMed
- Adv Chronic Kidney Dis. 2014 Mar;21(2):121-33 - PubMed
- Biochem Biophys Res Commun. 2013 Apr 12;433(3):292-7 - PubMed
- Clin Ther. 2005 Aug;27(8):1164-80 - PubMed
- Nat Genet. 2000 Jan;24(1):36-44 - PubMed
- Curr Mol Med. 2014;14(9):1103-25 - PubMed
- Physiol Rev. 2005 Oct;85(4):1255-70 - PubMed
- Biochem Biophys Res Commun. 2004 Apr 16;316(4):1094-100 - PubMed
- Nature. 2003 Dec 18;426(6968):891-4 - PubMed
- Diabetologia. 2012 Feb;55(2):392-403 - PubMed
- J Gerontol A Biol Sci Med Sci. 1999 Nov;54(11):M541-5 - PubMed
- Pancreas. 2004 Aug;29(2):e51-8 - PubMed
- J Clin Invest. 2006 Jul;116(7):1802-12 - PubMed
- PLoS One. 2014 Aug 07;9(8):e102843 - PubMed
- ILAR J. 2006;47(3):225-33 - PubMed
- Physiol Rev. 2014 Jul;94(3):909-50 - PubMed
- Endocrinology. 2009 Nov;150(11):4855-62 - PubMed
- Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jul;30(7):1530-3 - PubMed
- World J Diabetes. 2011 Jul 15;2(7):114-8 - PubMed
- Mol Genet Metab. 2011 Dec;104(4):648-53 - PubMed
- J Pharmacol Exp Ther. 2015 Sep;354(3):279-89 - PubMed
- J Cell Biol. 2001 Nov 12;155(4):519-30 - PubMed
- Diabetes. 2003 Jan;52(1):124-32 - PubMed
- Diabetes. 2002 Dec;51 Suppl 3:S455-61 - PubMed
- Endocrinology. 1999 Aug;140(8):3422-8 - PubMed
- J Clin Invest. 2002 Nov;110(10 ):1389-98 - PubMed
- Diabetes Obes Metab. 2011 Oct;13 Suppl 1:126-32 - PubMed
- Diabetes. 2010 Oct;59(10):2340-8 - PubMed
- Biochem Biophys Res Commun. 2002 Mar 1;291(3):649-54 - PubMed
- J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S250-3 - PubMed
- Free Radic Biol Med. 1996;20(3):463-6 - PubMed
Publication Types